University of Pittsburgh
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pittsburgh sits in the top decile of US sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count).
University of Pittsburgh: 1,238 sponsored US clinical trials, 160 recruiting.
University of Pittsburgh sponsors 1,238 registered US clinical trials on ClinicalTrials.gov, 160 of them currently recruiting, and 917 completed. 84 of these trials are in Phase 3-4 (later-stage) and 160 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of Pittsburgh ranks in the top decile of sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
917 of 1,014 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,238 total, page 3 of 25
Reducing Alcohol Involved Sexual Violence in Higher Education
NCT05185440
An Augmented Reality Based System for Neglect Detection, Assessment, and Rehabilitation
NCT04187131
Music Listening: A Mechanistic Trial
NCT05541029
Effect of Raised End-Tidal pCo2 on Choroidal Volume
NCT06275308
RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty
NCT05658796
Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention
NCT05748730
The Effects of Medicaid Policy Interventions on Racial Equity in Severe Maternal Morbidity
NCT05678699
Digital Therapeutics for Behavior Problems
NCT05647772
Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period
NCT04939012
Brain, Emotions, and Mind-Wandering
NCT05345392
Speech Signals in Stuttering
NCT05668923
Relationship of Inflammation and Pulmonary Function to Fungal Translocation in HIV
NCT05502653
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
NCT05450978
Caregiver Stress and Sleep Study
NCT05219955
Cortical Excitability in Cyclic Vomiting Syndrome
NCT05256160
Skills Group for Youth at Clinical High-Risk for Psychosis
NCT05398120
Harm Reduction in HIV Primary Care for PLWH Who Use Drugs
NCT05404750
Circadian Rhythms and Homeostatic Sleep Drive and Their Effect on Reward and Cognitive Control Systems in Adolescents
NCT05336084
Open Versus Arthroscopic Stabilization of Shoulder Instability With Subcritical Bone Loss: The OASIS Trial
NCT04809064
Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis
NCT04996628
Time-in-bed Restriction in Older Adults With Sleep Difficulties With and Without Risk for Alzheimer's Disease
NCT05138848
Cognitive and Affective Mechanisms Underlying an Olfactory Approach to Modify Cigarette Craving
NCT04902469
SKIP for PA Study: Team and Leadership Level Implementation Support for Collaborative Care
NCT04946253
Increasing Gait Automaticity in Older Adults by Exploiting Locomotor Adaptation
NCT04934956
Clarifying the Optimal Application of SLT Therapy Trial
NCT04967989
Early Intervention for Youth at High Risk for Bipolar Disorder
NCT04815239
Fear of Recurrence and Stopping Immunotherapy
NCT04761328
Experimental Manipulation of Sleep and Circadian Rhythms and the Role Played on Reward Function in Teens
NCT04792697
Autologous Ovarian Tissue Transplantation
NCT03496636
Project THINK: Trajectories of Health, Ingestive Behaviors, and Neurocognition in Kids
NCT04701671
Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia
NCT04109820
Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES)
NCT04143126
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
NCT02592291
Project REST: Regulation of Eating and Sleep Topography
NCT04057716
Genetic and Epigenetic Basis of Chronic Wounds
NCT03793062
Molecular and Cellular Characterization of Skull Base Tumors
NCT03759717
Neurogenetics Patient Registry
NCT02995538
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
NCT02994121
Amish/Mennonite Research Contact Registry
NCT02990572
Exome and Genome Analysis to Elucidate Genetic Etiologies and Population Characteristics in the Plain Community
NCT02927158
Mapping Disease Pathways for Biliary Atresia
NCT03273049
MyPaTH Story Booth
NCT03494075
Natural History and Advanced Genetic Study of Pyruvate Dehydrogenase Complex Deficiencies
NCT03056794
Molecular Basis of Pediatric Liver Cancer
NCT03959800
Longitudinal Study of Neurodegenerative Disorders
NCT03333200
Ovarian Tissue Cryopreservation for Fertility Preservation
NCT05875155
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum
NCT01042548
Testicular Tissue Cryopreservation for Fertility Preservation
NCT02972801
Inflammatory Bowel Disease (IBD) Research Registry
NCT04243525
Mechanisms Underlying Impaired Diabetic Wound Healing
NCT00777712
What is open in the University of Pittsburgh pipeline
160 recruiting of 1,238 indexed (13% open); 917 completed (74%).
Phase mix: 84 late (III/IV) vs 160 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Pittsburgh: open-pipeline peers nationwide
Peers matched on 1,238 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,238 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Intermountain Health Care · 13% recruiting · 85 trials
- McMaster University · 13% recruiting · 31 trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 13% recruiting · 93 trials
- Temple University · 13% recruiting · 163 trials
Related
What to do with this University of Pittsburgh page
1,238 registered trials is a research-attention snapshot, not an endorsement of University of Pittsburgh or any single study.
- 160 of University of Pittsburgh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Pittsburgh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Pittsburgh pipeline card: 1,238 registered trials from official public datasets.Report a data error.